Azenta (AZTA) Shares Outstanding (Diluted Average) (2010 - 2026)
Azenta (AZTA) recorded quarterly Shares Outstanding (Diluted Average) of $46.1 million in Q1 2026, little changed quarter-over-quarter from $45.9 million in Q4 2025, and up 0.72% on a YoY basis from $45.7 million in Q1 2025.
Azenta (AZTA) Shares Outstanding (Diluted Average) (2010 - 2026) Analysis & Trends
Azenta's Shares Outstanding (Diluted Average) history runs 13 years deep, the most recent figure standing at $46.1 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Diluted Average) rose 0.72% year-over-year to $46.1 million; the TTM figure through Mar 2026 stood at $46.1 million (up 0.72% YoY), while the FY2025 annual figure was $45.9 million, changed N/A from the prior year.
- Shares Outstanding (Diluted Average) was $46.1 million for Q1 2026 at Azenta, roughly flat from $45.9 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $74.9 million in Q3 2022 to a low of $45.6 million in Q4 2024.
- Historically, Shares Outstanding (Diluted Average) has averaged $53.9 million across 5 years, with a median of $53.2 million in 2024.
- The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Diluted Average) dropped 19.74% in 2024, then advanced 0.72% in 2026.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $74.9 million in 2022, then fell by 24.28% to $56.7 million in 2023, then decreased by 19.54% to $45.6 million in 2024, then climbed by 0.66% to $45.9 million in 2025, then increased by 0.29% to $46.1 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $46.1 million (Q1 2026), $45.9 million (Q4 2025), and $46.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 359.80 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 824.84 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 145.72 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 72.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 175.50 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 195.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 71.61 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Azenta | 1.06 Bn | 682.62 Mn | 62.04 Mn | 46.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.06 Mn |
| Dec 31, 2025 | 45.93 Mn |
| Sep 30, 2025 | 45.99 Mn |
| Jun 30, 2025 | 45.78 Mn |
| Mar 31, 2025 | 45.73 Mn |
| Dec 31, 2024 | 45.63 Mn |
| Sep 30, 2024 | 53.18 Mn |
| Jun 30, 2024 | 54.91 Mn |
| Mar 31, 2024 | 56.08 Mn |
| Dec 31, 2023 | 56.71 Mn |
| Sep 30, 2023 | 66.25 Mn |
| Jun 30, 2023 | 63.43 Mn |
| Sep 30, 2022 | 74.90 Mn |
| Mar 31, 2017 | 70.07 Mn |
| Dec 31, 2016 | 69.87 Mn |
| Sep 30, 2016 | 68.51 Mn |
| Jun 30, 2016 | 69.17 Mn |
| Mar 31, 2016 | 68.56 Mn |
| Dec 31, 2015 | 68.13 Mn |
| Sep 30, 2015 | 68.55 Mn |